Nasdaq Agle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq agle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Agle Today - Breaking & Trending Today

Aeglea BioTherapeutics (NASDAQ:AGLE) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Aeglea BioTherapeutics Stock Performance The stock has a market cap of $48.64 million, a PE ratio of -0.16 and a beta of 2.57. The company […] ....

Aeglea Biotherapeutics , Vr Adviser , Driehaus Capital Management , Goldman Sachs Group Inc , Affinity Asset Advisors , Aeglea Biotherapeutics Company Profile , Aeglea Biotherapeutics Inc , Free Report , Asset Advisors , Capital Management , Goldman Sachs Group , Get Free Report , Nasdaq Agle , Initiated Coverage , Stocknews Com ,

Aeglea BioTherapeutics (NASDAQ:AGLE) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Wells Fargo & Company increased their target price on shares of Aeglea BioTherapeutics from $8.75 to $12.50 and gave the stock an equal weight […] ....

Aeglea Biotherapeutics , Goldman Sachs Group Inc , Wells Fargo Company , Aeglea Biotherapeutics Company Profile , Sphera Funds Management , Aeglea Biotherapeutics Inc , Charles Schwab Investment Management Inc , Free Report , Wells Fargo , Sachs Group , Schwab Investment Management , Sigma Advisers , Funds Management , Two Sigma Investments , Sigma Investments , Get Free Report , Nasdaq Agle , Initiated Coverage , Stocknews Com ,

Aeglea BioTherapeutics (AGLE) Set to Announce Quarterly Earnings on Wednesday

Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, November 1st. Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) last posted its earnings results on Friday, August 11th. The biotechnology company reported ($41.50) EPS for the quarter, missing analysts’ consensus estimates of ($4.50) by ($37.00). The company had […] ....

Stifel Nicolaus , Aeglea Biotherapeutics , Wells Fargo Company , Aeglea Biotherapeutics Company Profile , Goldman Sachs Group Inc , Sphera Funds Management , Renaissance Technologies , Aeglea Biotherapeutics Inc , Millennium Management , Get Free Report , Sachs Group , Funds Management , Two Sigma Investments , Sigma Investments , Nasdaq Agle ,

Aeglea BioTherapeutics (NASDAQ:AGLE) Cut to Sell at StockNews.com

StockNews.com downgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research note published on Tuesday morning. Several other research firms have also commented on AGLE. Stifel Nicolaus started coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They issued a buy […] ....

Stifel Nicolaus , Aeglea Biotherapeutics , Wells Fargo Company , Charles Schwab Investment Management Inc , Aeglea Biotherapeutics Inc , Nantahala Capital Management , Acadian Asset Management , Free Report , Get Free Report , Asset Management , Capital Management , Schwab Investment Management , Street Corp , Rock Springs Capital Management , Springs Capital Management , Nasdaq Agle , Stocknews Com ,

Aeglea BioTherapeutics (NASDAQ:AGLE) Downgraded by StockNews.com to "Sell"

StockNews.com cut shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Several other research analysts have also weighed in on the stock. Stifel Nicolaus assumed coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They set […] ....

Stifel Nicolaus , Aeglea Biotherapeutics , Driehaus Capital Management , Vr Adviser , Aeglea Biotherapeutics Inc , Aeglea Biotherapeutics Company Profile , Goldman Sachs Group Inc , Affinity Asset Advisors , Wells Fargo Company , Free Report , Get Free Report , Asset Advisors , Sachs Group , Capital Management , Nasdaq Agle , Stocknews Com ,